Gradalis

Gradalis is a biotechnology company that focuses on the development and commercialization of novel personalized therapeutics to treat cancer. Gradalis is a drug manufacturer and developer of vaccines, tools and diagnostics for the treatment of cancer. The company is developing and testing Vigil®, a fully personalized and patient-specific cancer immunotherapy that can be applied to any cancer.

Its leadership team consists of experienced professionals in scientific, medical research, and technology. Vigil is intended to stimulate and enhance the body’s natural mechanism for recognizing and killing cancer cells, it uses the patient’s own cancer cells to develop a fully personalized cancer immunotherapy with the goal of activating the patient’s own T-cells against their cancer cells.